RetractedArticleMolecular medicine (Cambridge, Mass.)2012

Delayed administration of pyroglutamate helix B surface peptide (pHBSP), a novel nonerythropoietic analog of erythropoietin, attenuates acute kidney injury.

Nimesh S A Patel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.